ROBERTO
MUÑOZ AGUILERA
Profesor asociado de Ciencias de la Salud
![Foto de ROBERTO](/img/nophoto.png)
![Foto de Hospital Universitario Virgen de la Victoria](/img/noimage_org.png)
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen de la Victoria (8)
2023
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
2022
-
Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing
PLoS ONE, Vol. 17, Núm. 2 February
-
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing
Journal of Clinical Medicine, Vol. 11, Núm. 20
2021
-
Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival
Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21
2020
-
Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283
2019
-
Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices
Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275
-
Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis
International Journal of Cardiology, Vol. 274, pp. 163-169
2018
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial
European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264